Colorado BioScience Association Announces Record-Breaking Attendance at Vail Investor Conference

Rocky Mountain Life Sciences Investor & Partnering Conference to Welcome More than 200 Attendees

Denver – Colorado BioScience Association (CBSA) will highlight the future of health innovation at the Rocky Mountain Life Sciences Investor and Partnering Conference in Vail, Colo. on September 13 and 14. The conference connects the region’s most promising life sciences companies with investors and strategic partners from across the country.

Returning for the first time since 2019, the conference will welcome more than 200 attendees, including 60 life sciences presenting companies. Other attendees at the event, held at the Grand Hyatt Vail, include investors and strategic partners, service providers, and industry thought leaders. The agenda includes pitches from 30 life sciences companies, inspiration from a leading advocate for leading-edge cancer treatments, insights on the life sciences investment landscape, and dedicated time for partnering and networking.

“The caliber of life sciences innovations from the Rocky Mountain West is attracting top investors and strategic partners from across the U.S.,” said Elyse Blazevich, President and CEO of Colorado BioScience Association. “With the record-breaking registrations, it will be a dynamic and productive conference for our presenting companies, investors, and strategic partners.”

Presenting companies include 30 medtech, biotechnology, pharmaceutical, and digital health innovators, seeking between $1.5 million and $100 million in funding.   

Presenting Companies

Aesthetics Biomedical  Funding Sought: $15M  ImidexFunding Sought: $1.5M  
ArpeggioFunding Sought: Medecipher Solutions  Funding Sought: $2M – $2.5M  
Aspero Medical  Funding Sought: $5MnView medical  Funding Sought: $10M  
Burst Diagnostics  Funding Sought: $2.5M  ReglageneFunding Sought: $3.5M  
CaliberMRI  Funding Sought: $2.5M  RheumaGenFunding Sought: $20M – $30M  
Ceria Therapeutics  Funding Sought: $5M  Securisyn Medical  Funding Sought: $20M
Certus Critical Care  Funding Sought: $10M  SinuTec, Inc.Funding Sought: $1.25M
ClinOne  Funding Sought: $8 – $10MSTAQ Pharma  Funding Sought: $30M  
CorNav  Funding Sought: $5M   Think Bioscience  Funding Sought: Recently completed Seed. Interested in meeting potential partners and investor for Series A round.  
EnteroTrack  Funding Sought: $10M  Validus Cellular Therapeutics  Funding Sought: $10M  
Flourish Medical  Funding Sought: $2M  Vesicle Therapeutics  Funding Sought: $25M  
ForCast Orthopedics  Funding Sought: $5M – $6M  Vibliome Therapeutics  Funding Sought: $50M  
Foresight Diagnostics  Funding Sought: vitro3D  Funding Sought: $2M  
GelSana TherapeuticsFunding Sought: $8M   Vona Oncology  Funding Sought: $5M – $10M  
 HepQuant   Funding Sought: $20M – $100M  ZelosDx  Funding Sought: $1.5M  

The Rocky Mountain Life Sciences Investor and Partnering Conference will also feature thought leaders who will highlight the importance and impact of health innovations.

Keynote Speaker: Tom Whitehead, President and Co-Founder, Emily Whitehead Foundation
Emily Whitehead, Tom’s daughter, is alive today because of cutting-edge cancer research.  As the first pediatric patient in the world to receive CAR T-cell therapy after a terminal acute lymphoblastic leukemia (ALL) prognosis, Emily is more than 10 years cancer-free. Tom speaks internationally to share Emily’s story and to raise awareness for pediatric cancer immunotherapy research.

Panel Discussion: Emerging Investment Trends to Propel Life-Saving Innovations 

  • Vikram Chaudhery, Ph.D., Partner at Genoa Ventures and Co-Founder & President of General Inception
  • David Uffer, VP of Commercial Development, General Inception
  • Kwame Ulmer, Venture Partner, Wavemaker Three-Sixty Health
  • Elizabeth Wu, Ph.D., Director, Early Innovation Partnering, Johnson & Johnson Innovation
  • Eric Zimmerman, Principal Healthcare & Life Sciences BD, Venture Capital & Startups, Amazon Web Services (AWS)
  • Moderator: Michael Weiner, Partner, Dorsey and Whitney

Limited registrations for investors, strategic partners, and life sciences companies are available. Currently, CBSA is maintaining a wait list for service providers.

About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more:

# # #

Media Contact
Sheliah Reynolds
Primavera Group for Colorado BioScience Association
(720) 289-4739

Categories: CBSA News